NCT03610776 (PORTIONS) is a NA clinical trial of Portion control plate in Portion Size, sponsored by Clinica Universidad de Navarra, Universidad de Navarra.

Who is sponsoring NCT03610776?

NCT03610776 is sponsored by Clinica Universidad de Navarra, Universidad de Navarra.

What drugs are being tested in NCT03610776?

Interventions in NCT03610776: Portion control plate, Conventional plate.

What condition does NCT03610776 study?

NCT03610776 studies Portion Size.

Is NCT03610776 still recruiting?

NCT03610776 is currently completed. Last updated 18 June 2020.

Last reviewed 2020-06-18 · How we verify

NCT03610776: PORTIONS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Tableware Visual Cues on Portion Control and Eating Rate

Completed NA Last updated 18 June 2020

What this trial tests

NA trial testing Portion control plate in Portion Size in 76 participants. Completed in 15 June 2020.

Timeline

19 June 2017

Primary endpoint
31 May 2020

15 June 2020

Quick facts

Lead sponsor	Clinica Universidad de Navarra, Universidad de Navarra
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	basic science
Enrollment	76
Start date	19 June 2017
Primary completion	31 May 2020
Estimated completion	15 June 2020
Sites	1 location across Spain

Drugs / interventions tested

Portion control plate
Conventional plate

Conditions studied

Portion Size — all drugs for Portion Size →

Sponsor

Clinica Universidad de Navarra, Universidad de Navarra

Who can join

Adults 18 to 60, any sex, with Portion Size. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Randomised within subjects cross-over study (n=94) exploring the cognitive and physiological processes associated with portion control. Participants will eat a self-served lunch using a portion control plate vs. a conventional (control) plate on two separate occasions under a controlled laboratory environment. Portion size, meal micro-structure, attention, memory and satiety markers will be analysed. The portion control plate is a prototype designed in collaboration with the commercial partner for this study and is based on published evidence. It includes sectors and pictures indicating amounts to serve from starchy food, protein and vegetables. The control plate will be of the same background colour, size and shape but without any pictures or demarcations. The main study outcome is attention time on areas of interest in the plate corresponding to main foods groups, across plate conditions.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Development and validation of a new methodological platform to measure behavioral, cognitive, and physiological responses to food interventions in real time.
Vargas-Alvarez MA, Al-Sehaim H, Brunstrom JM, Castelnuovo G, et al · · 2022 · cited 2× · PMID 35102518 · DOI 10.3758/s13428-021-01745-9

Verify or expand the search:

Other Clinica Universidad de Navarra, Universidad de Navarra trials

Trials by the same sponsor.

NCT07370571 — NO AXILLARY SURGERY IN EARLY BREAST CANCER (OXIGENATE) · not yet recruiting
NCT07165431 — Effect of a Postbiotic Supplementation in Overweight and Obese Subjects: A Randomized Controlled Trial (PARABIOTICS-2). · NA · recruiting
NCT07447440 — Role of Pro-Resolving Lipid Mediators in Obesity-Associated Diseases · recruiting
NCT07191210 — Co-Designed Comprehensive Transition Programme for First-Line Nurse Managers · NA · not yet recruiting
NCT07132060 — MRI-guided Dose Intensification Program Locally Advanced Pancreatic Cancer · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03610776 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Clinica Universidad de Navarra, Universidad de Navarra
Last refreshed: 18 June 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03610776.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing